Icagen is a startup based in the United States, most recent round Series-c-plus.
Icagen is a company headquartered in the United States. Its most recent tracked round is Series-c-plus.
Icagen was a U.S.-based drug development company focused on inflammation. The company was listed on NASDAQ in 2004.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.